| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1023/A:1014474414097 |
| P698 | PubMed publication ID | 11934227 |
| P2093 | author name string | Lars Hovgaard | |
| Camilla Foged | |||
| Anne Sundblad | |||
| P2860 | cites work | Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 |
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes | Q28609747 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant | Q33368912 | ||
| Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells? | Q33669603 | ||
| Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. | Q33699321 | ||
| Advances in vaccine adjuvants | Q33764666 | ||
| Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery | Q33878517 | ||
| Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep | Q34002743 | ||
| Dendritic cell based tumor vaccines | Q34038736 | ||
| Modulating the immune response with dendritic cells and their growth factors | Q34207541 | ||
| The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing | Q34310837 | ||
| A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge | Q35796391 | ||
| DNA vaccination: transfection and activation of dendritic cells as key events for immunity | Q35834601 | ||
| Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages | Q36327656 | ||
| The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments | Q36342606 | ||
| Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo | Q36362128 | ||
| Maturation, activation, and protection of dendritic cells induced by double-stranded RNA | Q36367830 | ||
| Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization | Q36367948 | ||
| Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells | Q36375909 | ||
| Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures | Q36376739 | ||
| Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells | Q36401207 | ||
| The endocytic activity of dendritic cells. | Q40457008 | ||
| The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep. | Q40788843 | ||
| Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. | Q40823709 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector | Q40951294 | ||
| Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. | Q41049213 | ||
| MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells | Q41339121 | ||
| Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin | Q41578917 | ||
| Dendritic cells: unique leukocyte populations which control the primary immune response | Q41621775 | ||
| The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand | Q42012073 | ||
| The role of aquaporins in dendritic cell macropinocytosis | Q42094703 | ||
| Mobilizing dendritic cells for tolerance, priming, and chronic inflammation | Q42576422 | ||
| Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites | Q42971765 | ||
| Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries? | Q42972756 | ||
| Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells | Q43552844 | ||
| Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model | Q45871631 | ||
| Targeting dendritic cells to enhance DNA vaccine potency. | Q45876754 | ||
| Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine | Q46465209 | ||
| Phagocytic processing of bacterial antigens for class I MHC presentation to T cells | Q50167043 | ||
| Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. | Q50335818 | ||
| Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. | Q50335820 | ||
| Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. | Q52041455 | ||
| Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. | Q54009055 | ||
| The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens | Q56966367 | ||
| Phenotypic and Functional Maturation of Dendritic Cells Mediated by Heparan Sulfate | Q56967640 | ||
| TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells | Q57218941 | ||
| The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells | Q57275938 | ||
| CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis | Q57275941 | ||
| Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability | Q71615065 | ||
| Antigens linked to synthetic microspheres induce immune responses in primates in the absence of adjuvant | Q71643796 | ||
| The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells | Q73084737 | ||
| Effect of interleukin-10 on dendritic cell maturation and function | Q73396250 | ||
| Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand | Q73548846 | ||
| Oligosaccharides of hyaluronan are potent activators of dendritic cells | Q74108237 | ||
| Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis | Q74268258 | ||
| Fully mobilizing host defense: building better vaccines | Q77608031 | ||
| Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells | Q77785419 | ||
| A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells | Q78025415 | ||
| P433 | issue | 3 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 229-238 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Targeting vaccines to dendritic cells | |
| P478 | volume | 19 |
| Q64377728 | CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation |
| Q40062912 | Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity |
| Q59235261 | Effect of incorporation of the adjuvant Quil A on structure and immune stimulatory capacity of liposomes |
| Q41124574 | Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P. falciparum surface antigen, MSP-119. |
| Q38648991 | Elastic liposomes as novel carriers: recent advances in drug delivery. |
| Q40327793 | Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles |
| Q30391225 | Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly |
| Q34960453 | Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro |
| Q94199186 | Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles |
| Q44879296 | Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition |
| Q34309830 | Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives. |
| Q38051096 | Nanocarriers targeting dendritic cells for pulmonary vaccine delivery |
| Q35624557 | Nanoliposomes of L-lysine-conjugated poly(aspartic acid) Increase the Generation and Function of Bone Marrow-derived Dendritic Cells |
| Q36574571 | Nanoparticle delivery systems in cancer vaccines. |
| Q90383852 | Nanoparticles Targeting STATs in Cancer Therapy |
| Q41986626 | Novel Injectable Pentablock Copolymer Based Thermoresponsive Hydrogels for Sustained Release Vaccines |
| Q40473345 | Polymer-mediated DNA vaccine delivery via bystander cells requires a proper balance between transfection efficiency and cytotoxicity. |
| Q40390251 | Recombinant adenovirus type 5 vectors that target DC-SIGN, ChemR23 and alpha(v)beta3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens |
| Q39549087 | Recombinant monomeric CD40 ligand for delivering polymer particles to dendritic cells |
| Q42157286 | Transdermal immunization of P. falciparum surface antigen (MSP-119) via elastic liposomes confers robust immunogenicity |
| Q42037581 | Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice |
| Q35848627 | Ultrasound and transdermal drug delivery. |
Search more.